The Ulcerative Colitis Clinical Trial at Velocity Clinical Research Facility

Are You Eligible to Take Part in this Study?

Do you suffer from mild-to-moderate ulcerative colitis? If so, you may be eligible to participate in a Velocity Clinical Research ulcerative colitis clinical trial. Eligible volunteers must be adults, between the ages of 18 and 70 who have been diagnosed with ulcerative colitis.

Clinical trial volunteers may be compensated for their time and travel, there are no costs for the medical procedures or treatments and there is no insurance necessary to participate in clinical trials. Clinical research participants play a more active role in their healthcare, and may also benefit from advanced treatments before they are made available to the public…and, of course, every clinical study participant makes a difference, playing their own vital role in the advancement of medical research and a brighter future for generations to come.

The Study

This Velocity Clinical Research ulcerative colitis clinical trial is sponsored by Shanghai Pharma Biotherapeutics USA Inc. (SPHBio). The purpose of this particular ulcerative colitis study is to learn more about study drug SPH3127 in terms of its potential effectiveness in treatment and how it affects the body. 

If eligible, clinical study volunteers will take part in a minimum of five outpatient visits, including two endoscopies taking place over the course of two months. There is also an optional active treatment extension of up to ten months with an additional endoscopy. There is absolutely no obligation for parties interested in volunteering for this study to participate and study participants may withdraw at any time. 

Study participants who do decide to participate will have a two out of three chance of receiving the actual study drug and a one out of three chance of during the first clinical trial phase. All participants in this study’s extension phase will receive the actual study medication.

Ulcerative Colitis 

Common in ages from 18 to 35 and with over 200,000 cases per year in the United States, ulcerative colitis is an inflammation and ulceration of the colon and rectum, causing stomach pain and cramping. If you think you may be suffering from ulcerative colitis, medical attention, which often requires lab testing and imaging, is recommended. There is currently no known cure of ulcerative colitis, but treatment may greatly alleviate symptoms and help to manage this condition – possibly even to the point of long-term remission.

The Causes of Ulcerative Colitis

Although the exact cause of ulcerative colitis is also unknown, family history can increase the likelihood of the development of ulcerative colitis. Age (The onset of ulcerative colitis is more prevalent around the age of 30.) and ethnicity (The Jewish population is more prone to ulcerative colitis development.) can also play a role in ulcerative colitis development; and poor dietary habits and stress can aggravate ulcerative colitis. Additionally, an overactive immune system which attacks the digestive system is one suspected cause of colitis.

Symptoms of Ulcerative Colitis

Aside from abdominal pain and cramping, symptoms of ulcerative colitis, which can vary depending on severity and specific location, may include rectal pain, blood in the stool or diarrhea with blood or puss, an urgency to defecate, weight loss, fatigue and fever. Most people suffering from ulcerative colitis experience mild to moderate symptoms which develop over time.

Left untreated, complications of ulcerative colitis may include dehydration, inflammation of the color, skin, joints or eyes, more severe bleeding, perforated colon, osteoporosis, and even the increased risk for colon cancer and blood clots.

Diagnosing Ulcerative Colitis

The only way to definitively diagnose ulcerative colitis is with endoscopic procedures and tissue biopsies. However, other medical tests may be performed to pinpoint certain indicators of ulcerative colitis or to rule out other conditions. For example, blood tests may be used to check for infection; stool samples may be studied to search for bacteria, viruses and parasites; an X-ray may be used to rule out a perforated colon; and a CT scan can check for the complication of an inflamed colon.

Treating Ulcerative Colitis

Drugs – including anti-inflammatories, immune system suppressors, biologics, anti-diarrheal medications, antispasmodics and iron supplements – may be prescribed on their own or in various combinations depending upon the specifics of each ulcerative colitis case. Surgery to remove the colon and rectum may be used in more dire circumstances. 

Velocity Clinical Research

An award-winning research facility, Riverside Clinical Research, has earned an impeccable reputation for clinical research trial trendsetting. The experienced doctors and research professionals at the Velocity Clinical Research facility work one-on-one with clinical trial volunteers to discover and develop innovations in healthcare. One of the most elite medical research facilities in this entire area, Velocity Clinical Research, conveniently located at 1410 S. Ridgewood Avenue in Edgewater, is equipped to support up to 26 in-house patients as well as a large number of outpatients. 

If you think you may be interested helping to build a better tomorrow by taking part in this clinical research study, please feel free to call Velocity Clinical Research for more information at 386-428-7730 Monday through Thursday from 7 a.m. to 5 p.m. or Friday from 7 a.m. to 12 p.m. Thank you for your interest in the betterment of healthcare.